Daniela Massierer1, Waleed Alsowayan2, Vanessa Pereira Lima3, Jean Bourbeau4, Tania Janaudis-Ferreira5. 1. School of Physical and Occupational Therapy, McGill University, 3654 Prom Sir-William-Osler, Hosmer House, Room #200, Montreal, QC, H3G 1Y5, Canada; Translational Research in Respiratory Diseases Program, Research Institute of the McGill University Health Centre, 1001 Decarie Blvd, Block E, Montreal, QC, H4A 3J1, Canada; Centre for Health Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, 5252 Boul. de Maisonneuve Ouest, Room # 3E.01, Montreal, QC, H4A 3S5, Canada. 2. Respiratory Division, McGill University Health Center, 1001 Decarie Blvd, Montreal, QC, H4A 3J, Canada. 3. Department of Physical Therapy, Universidade Federal dos Vales do Jequitinhonha e Mucuri-UFVJM, Campus JK, Rodovia MGT 367, Km 583, Nº 5000, Alto da Jacuba CEP: 39100-000, Diamantina, Minas Gerais, Brazil. 4. Respiratory Epidemiology and Clinical Research Unit (RECRU), McGill University Health Centre, 5252 Boul. de Maisonneuve Ouest, Montreal, QC, H4A 3S5, Canada; Translational Research in Respiratory Diseases Program, Research Institute of the McGill University Health Centre, 1001 Decarie Blvd, Block E, Montreal, QC, H4A 3J1, Canada. 5. School of Physical and Occupational Therapy, McGill University, 3654 Prom Sir-William-Osler, Hosmer House, Room #200, Montreal, QC, H3G 1Y5, Canada; Respiratory Epidemiology and Clinical Research Unit (RECRU), McGill University Health Centre, 5252 Boul. de Maisonneuve Ouest, Montreal, QC, H4A 3S5, Canada; Translational Research in Respiratory Diseases Program, Research Institute of the McGill University Health Centre, 1001 Decarie Blvd, Block E, Montreal, QC, H4A 3J1, Canada; Centre for Health Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, 5252 Boul. de Maisonneuve Ouest, Room # 3E.01, Montreal, QC, H4A 3S5, Canada. Electronic address: tania.janaudis-ferreira@mcgill.ca.
Abstract
PURPOSE: There has been an increased interest in simple measures of physical function and muscle strength that can be used in all clinical settings to assess individuals with chronic obstructive pulmonary disease (COPD) and predict their prognosis. The main objective was to examine the prognostic value of simple measures of physical function and muscle strength in relation to exacerbation, hospitalization and mortality in individuals with COPD. METHODS: Medline, EMBASE, Cochrane and Web of Science were searched. We included prospective observational studies that examined the prognostic value of simple performed-based tests or self-reported measures of physical function or muscle strength in relation to exacerbation, hospitalization and mortality in individuals with COPD. RESULTS: Seven articles met the inclusion criteria. The most commonly used tests were the handgrip strength (HGS) (n = 4) and 1-min sit-to-stand (STS) (n = 2). There were considerable variations in terms of characteristics of patients included, setting of recruitment, type of tests used, duration of follow-up and outcome measures of interest. The majority of the studies were classified as having "fair" or "poor" methodological quality. CONCLUSIONS: There is a limited number of studies examining the prognostic value of simple measures of physical function and muscle strength in relation to exacerbations, hospitalizations and mortality in individuals with COPD. To date, the HGS and 1-min STS tests are the most studied tests and seem to be suitable for prognosis purposes in individuals with COPD. However, more studies with better methodological quality are needed to confirm these findings.
PURPOSE: There has been an increased interest in simple measures of physical function and muscle strength that can be used in all clinical settings to assess individuals with chronic obstructive pulmonary disease (COPD) and predict their prognosis. The main objective was to examine the prognostic value of simple measures of physical function and muscle strength in relation to exacerbation, hospitalization and mortality in individuals with COPD. METHODS: Medline, EMBASE, Cochrane and Web of Science were searched. We included prospective observational studies that examined the prognostic value of simple performed-based tests or self-reported measures of physical function or muscle strength in relation to exacerbation, hospitalization and mortality in individuals with COPD. RESULTS: Seven articles met the inclusion criteria. The most commonly used tests were the handgrip strength (HGS) (n = 4) and 1-min sit-to-stand (STS) (n = 2). There were considerable variations in terms of characteristics of patients included, setting of recruitment, type of tests used, duration of follow-up and outcome measures of interest. The majority of the studies were classified as having "fair" or "poor" methodological quality. CONCLUSIONS: There is a limited number of studies examining the prognostic value of simple measures of physical function and muscle strength in relation to exacerbations, hospitalizations and mortality in individuals with COPD. To date, the HGS and 1-min STS tests are the most studied tests and seem to be suitable for prognosis purposes in individuals with COPD. However, more studies with better methodological quality are needed to confirm these findings.
Authors: Stefanie Elizabeth Mason; Rafael Moreta-Martinez; Wassim W Labaki; Matthew Strand; David Baraghoshi; Elizabeth A Regan; Jessica Bon; Ruben San Jose Estepar; Richard Casaburi; Merry-Lynn N McDonald; Harry Rossiter; Barry J Make; Mark T Dransfield; MeiLan K Han; Kendra A Young; Greg Kinney; John E Hokanson; Raul San Jose Estepar; George R Washko Journal: Thorax Date: 2021-02-11 Impact factor: 9.139
Authors: Nicholas Bourgeois; Shirin M Shallwani; Fahad S Al-Huda; Sunita Mathur; Charles Poirier; Tania Janaudis-Ferreira Journal: Transplant Direct Date: 2022-10-07
Authors: Erik Frykholm; Sarah Gephine; Didier Saey; Arthur Lemson; Peter Klijn; Eline Bij de Vaate; François Maltais; Hieronymus van Hees; André Nyberg Journal: Sci Rep Date: 2021-06-02 Impact factor: 4.379